For the week ending March 21, 2025, my proprietary Canadian Cannabis Company Index (MCCCI) was unchanged compared to a decline of 7.5% in the prior week. This index, comprising 14 stocks, reflects the Canadian cannabis sector’s performance mainly influenced by prominent holdings within ETFs MJ​​​​​​, CNBS, and THCX. MCCCI's differentiated business model is both weighted and market capitalization-based because I believe this approach best represents the current landscape of the Canadian cannabis sector. Now, let us look at this week’s good, bad, and ugly stocks, shall we?

Image Source: Pixabay
 

The Good

There were no stocks that increased by more than 10%, which is my metric for inclusion in this category.
 

The Bad

There were no stocks that decreased by more than 10% (but less than 20%) which is my metric for inclusion in this category. 
 

The Ugly

There were no stocks that decreased by 20% or more, which is my metric for inclusion in this category:
 

Valuation Metric Review

The index’s “Big 4” stocks- CGC​​​​​​, CRON, TLRY, and TSNDF (3 of which increased) collectively saw an increase of 2.3% compared to a decline of 7.5% in the prior week. The stock-priced-based metric saw an increase of 2.5% compared to a decline of 7.5% in the prior week.
 

Recap

Out of the 14 stocks in the MCCCI 7 increased, which has not happened in quite some time. However, I do not see a reason to change the DEFCON level for the MCCI of 2. Let us see how this volatile sector has performed at the same time next week, shall we?

More By This Author:

The Canadian Cannabis Report - Monday, March 17
The Canadian Cannabis Report - Monday, March 10
The Canadian Cannabis Report - Monday, March 3